Anemia and mortality in patients with nondialysis-dependent chronic kidney disease

BACKGROUND: A combination of safety concerns and labeling changes impacted use of erythropoiesis-stimulating agents (ESAs) in renal anemia. Data regarding contemporary utilization in pre-dialysis chronic kidney disease (CKD) are lacking. METHODS: Electronic healthcare records and medical claims data...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Nephrol
Glavni autori: Stirnadel-Farrant, Heide A., Luo, Jiacong, Kler, Lata, Cizman, Borut, Jones, Delyth, Brunelli, Steven M., Cobitz, Alexander R.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5996482/
https://ncbi.nlm.nih.gov/pubmed/29890958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-0925-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items